CJC-1295 no DAC & Ipamorelin Degradation Reconstituted: Comparison of Storage Conditions and Potency Retention
The table below compares degradation timelines and potency retention for CJC-1295 no DAC and Ipamorelin under different storage conditions post-reconstitution. Data are based on stability studies of lyophilised GHRH analogues and ghrelin receptor agonists stor
This comparison does not assign a generated winner or score.
- The table below compares degradation timelines and potency retention for CJC-1295 no DAC and Ipamorelin under different storage conditions post-reconstitution. Data are based on stability studies of lyophilised GHRH analogues and ghrelin receptor agonists stored in bacteriostatic water.
- Refrigerated (standard)
- 2–8°C
- 90–95%
- 88–93%
- Slow hydrolysis, minimal oxidation
- Ideal for research use. 28-day viability with minimal loss
- Room temperature
- 20–25°C
- 50–60% (72 hours)
- 45–55% (72 hours)
- Rapid hydrolysis, oxidation, aggregation
- Unacceptable. Potency loss exceeds 40% within 3 days
- Frozen (single cycle)
- −20°C
- 75–85%
- 70–80%
- Ice crystal shearing, aggregation
- Not recommended. Freeze-thaw causes irreversible structural damage
- Refrigerated + light exposure
- 2–8°C, ambient light
- 80–85%
- 75–82%
- Photodegradation, oxidation of aromatic residues
- Suboptimal. Light-blocking storage increases retention by 10%
- Reconstituted in saline
- 85–90%
- 70–75%
- Ionic-strength-induced aggregation (Ipamorelin)
- Avoid for Ipamorelin. Saline reduces stability significantly
- Refrigerated, pH 7.5+
- Alkaline hydrolysis, deamidation
- CJC-1295 highly sensitive to alkaline pH. Use pH 5.5–6.5 water only
- The data confirm that refrigeration at 2–8°C with light protection and correct reconstitution medium (bacteriostatic water, pH 5.5–6.5) is the only storage protocol that preserves 90%+ potency for 28 days. Any deviation. Temperature, light, pH, or solvent. Introduces degradation pathways that shorten viable storage to days, not weeks.